I. C. M. MacLennan
- Immunology top 1%
- Radiology, Nuclear Medicine and Imaging top 2%
- Molecular Biology
- Oncology top 10%
- Epidemiology top 10%
- Co-authors
- Brian HardingG. LoewiD P JewellMontserrat Casamayor‐PallejaPeter HerseyHervé BazinDavid GrayH. E. M. Kay
- Topics
- Monoclonal and Polyclonal Antibodies Research (22 papers)T-cell and B-cell Immunology (19 papers)Macrophage Migration Inhibitory Factor (12 papers)
- Partner nations
- United KingdomFranceGermany
In The Last Decade
I. C. M. MacLennan
86 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 112
- Immunology 1.7k
- Radiology, Nuclear Medicine and Imaging 662
- Molecular Biology 556
- Oncology 437
- Epidemiology 417
Countries citing papers authored by I. C. M. MacLennan
This map shows the geographic impact of I. C. M. MacLennan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. C. M. MacLennan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. C. M. MacLennan more than expected).
Fields of papers citing papers by I. C. M. MacLennan
This network shows the impact of papers produced by I. C. M. MacLennan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. C. M. MacLennan. The network helps show where I. C. M. MacLennan may publish in the future.
Co-authorship network of co-authors of I. C. M. MacLennan
This figure shows the co-authorship network connecting the top 25 collaborators of I. C. M. MacLennan. A scholar is included among the top collaborators of I. C. M. MacLennan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. C. M. MacLennan. I. C. M. MacLennan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 198 | |
| 3 | 31 | |
| 4 | 109 | |
| 5 | 49 | |
| 6 | 45 | |
| 7 | Class and subclass anti-pneumococcal antibody responses in splenectomized patients. | 32 |
| 8 | 4 | |
| 9 | Regulation of secondary antibody responses in rodents. I. Potentiation of IgG production by cyclophosphamide. | 11 |
| 10 | 72 | |
| 11 | 33 | |
| 12 | Characteristics of the lymphopenia induced by radiotherapy | 33 |
| 13 | A method of measuring antibody- and phytohaemagglutinin-induced lymphocyte-dependent cytotoxicity using whole blood | 6 |
| 14 | 15 | |
| 15 | 24 | |
| 16 | 13 | |
| 17 | 56 | |
| 18 | 46 | |
| 19 | 78 | |
| 20 | The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non-immune lymphocytes. | 110 |
About I. C. M. MacLennan
I. C. M. MacLennan is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 88 papers that have together received 3.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (22 papers), T-cell and B-cell Immunology (19 papers) and Macrophage Migration Inhibitory Factor (12 papers). The work is most often cited by research in Immunology (1.7k citations), Hematology (330 citations) and Radiology, Nuclear Medicine and Imaging (662 citations). I. C. M. MacLennan has collaborated with scholars based in United Kingdom, France and Germany. Frequent co-authors include Brian Harding, G. Loewi, D P Jewell, Montserrat Casamayor‐Palleja, Peter Hersey, Hervé Bazin, David Gray, H. E. M. Kay, A. Howard and D S Kumararatne. Their work appears in journals such as Nature, The Lancet and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.